Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper

Autoimmunity Reviews

Volumn 9, Issue 4, 2010, Pages 216-223

  Ebringer, Alan ^a   Rashid, Taha ^a   Wilson, Clyde ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anti CCP antibodies; Karl Popper; Molecular mimicry; Proteus mirabilis; Rheumatoid arthritis

Indexed keywords

CITRULLINE; COLLAGEN TYPE 11; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HEMOLYSIN; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; PROTEIN ARGININE DEIMINASE; UREASE;

AMINO ACID SEQUENCE; BACTERIUM CULTURE; HUMAN; HYALINE CARTILAGE; MOLECULAR MIMICRY; PROTEUS; PROTEUS MIRABILIS; REVIEW; RHEUMATOID ARTHRITIS; URINE CULTURE;

ANIMALS; ANTIBODIES, BACTERIAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CITRULLINE; CROSS REACTIONS; EPITOPES; HEMOLYSIN PROTEINS; HLA-DR1 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; HYALINE CARTILAGE; MOLECULAR MIMICRY; PROTEUS INFECTIONS; PROTEUS MIRABILIS; URINARY TRACT INFECTIONS;

EID: 73649108211     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.10.006     Document Type: Review

References (46)

1. Ebringer A., and Rashid T. Rheumatoid arthritis is caused by Proteus: the molecular mimicry theory and Karl Popper. Front Biosci (Elite Ed) 1 (2009) 577-586
2. Popper K.R. The logic of scientific discovery (1959), Hutchinson, London
3. Popper K.R. Truth, rationality and the growth of scientific knowledge. In: Popper K.R. (Ed). Conjectures and Refutations (1969), London, Routledge and Kegan
4. Popper K.R. Objective Knowledge. An evolutionary approach (1972), Clarendon Press, Oxford
5. Klareskog L., Padyukov L., and Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19 (2007) 49-54
6. Aho K., Koskenvuo M., Tuominen J., and Kaprio J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 13 (1986) 899-902
7. Silman A.J., MacGregor A.J., Thomson W., Holligan S., Carthy D., Farhan A., et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32 (1993) 903-907
8. Svendsen A.J., Holm N.V., Kyvik K., Petersen P.H., and Junker P. Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. Br Med J 324 (2002) 264-266
9. Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 57 (1976) 1148-1157
10. Panayi G.S., and Wooley P.H. B-lymphocyte alloantigens in the study of the genetic basis of rheumatoid arthritis. Ann Rheum Dis 36 (1977) 365-368
11. Schiff B., Mizrachi Y., Orgad S., Yaron M., and Gazit E. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis 41 (1982) 403-404
12. Avouac J., Gossec L., and Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65 (2006) 845-851
13. Tedesco A., D'Agostino D., Soriente I., Amato P., Piccoli R., and Sabatini P. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach. Autoimmun Rev 8 (2009) 233-237
14. Anzilotti C., Pratesi F., Tommasi C., and Migliorini P. Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun Rev 9 (2010) 158-160
15. Gregersen P.K., Silver J., and Winchester R.J. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30 (1987) 1205-1213
16. Ebringer A., Rashid T., and Wilson C. Molecular mimicry as the basis of a new theory of autoimmunity. In: Zouali M. (Ed). Frontiers in Autoimmunity (2003), IOS Press, Amsterdam 79-99
17. Ebringer A., Ptaszynska T., Corbett M., Wilson C., Macafee Y., Avakian H., et al. Antibodies to Proteus in rheumatoid arthritis. Lancet ii (1985) 305-307
18. Ebringer A., Rashid T., and Wilson C. Rheumatoid arthritis: proposal for the early use of anti-bacterial therapy. Scand J Rheumatol 32 (2003) 2-11
19. Rogers P., Hassan J., Bresnihan B., Feighery C., and Whelan A. Antibodies to Proteus in rheumatoid arthritis. Br J Rheum 27 Suppl.2 (1988) 90-94
20. Fielder M., Tiwana H., Youinou P., Le Goff P., Deonarain R., Wilson C., et al. The specificity of the anti-Proteus antibody response in tissue typed rheumatoid arthritis (RA) patients from Brest. Rheumatol Int 15 (1995) 79-82
21. Senior B.W., McBride P.D.P., Morley K.D., and Kerr M.A. The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis. J Med Microbiol 43 (1995) 176-184
22. Kjeldsen-Kragh J., Rashid T., Dybwad A., Sioud M., Haugen M., Forre O., et al. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet. Ann Rheum Dis 54 (1995) 221-224
23. Subair H., Tiwana H., Fielder M., Binder A., Cunningham K., Ebringer A., Wilson C., and Hudson M.J. Elevation of anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. J Rheumatol 22 (1995) 1825-1828
24. Tani Y., Tiwana H., Hukuda S., Nishioka J., Fielder M., Wilson C., et al. Antibodies to Klebsiella, Proteus and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 24 (1997) 109-114
25. Wanchu A., Deodhar S.D., Sharma M., Gupta V., Bambery P., and Sud A. Elevated levels of anti-Proteus antibodies in patients with active rheumatoid arthritis. Ind J Med Res 105 (1997) 39-42
26. Blankenberg-Sprenkels S.H., Fielder M., Feltkamp T.E., Tiwana H., Wilson C., and Ebringer A. Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis. J Rheumatol 25 (1998) 743-747
27. Rashid T., Darlington G., Kjeldsen-Kragh J., Forre O., Collado A., and Ebringer A. Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis. Clin Rheumatol 18 (1999) 190-195
28. Ushakova M.A., Muravijuv U.V., Vaneeva N.P., Jastrebova N.E., Maslov I.I., and Zacharova J.E. The Proteus mirabilis antibody levels in patients with rheumatoid arthritis. (Abst.). Rheumatologia 14 (2000) 78
29. Rashid T., Leirisalo-Repo M., Tani Y., Hukuda S., Kobayashi S., Wilson C., et al. Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis. Clin Rheumatol 23 (2004) 134-141
30. Newkirk M.M., Goldbach-Mansky R., Senior B.W., Klippel J., Schumacher H.R., and El-Gabalawy H.S. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF) positive rheumatoid arthritis. Rheumatology (Oxford) 44 (2005) 1433-1441
31. Tiwana H., Wilson C., Walmsley R.S., Wakefield A.J., Smith M.S., Cox N.L., et al. Antibody response to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatol Int 17 (1997) 11-16
32. Ebringer A., Wilson C., Ahmadi K., Corbett M., Rashid T., and Shipley M. Rheumatoid arthritis as a reactive arthritis to Proteus infection: prospects for therapy. In: Machtey I. (Ed). Progress in Rheumatology (1993), Petach-Tiqva, Israel 77-83
33. Wilson C., Thakore A., Isenberg D., and Ebringer A. Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Rheumatol Int 16 (1997) 187-189
34. Rashid T., and Ebringer A. Rheumatoid arthritis is linked to Proteus-the evidence. Clin Rheumatol 26 (2007) 1036-1043
35. Wilson C., Ebringer A., Ahmadi K., Wrigglesworth J., Tiwana H., Fielder M., et al. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis 54 (1995) 216-220
36. Rashid T., Jayakumar K.S., Binder A., Ellis S., Cunningham P., and Ebringer A. Rheumatoid arthritis patients have elevated antibodies to cross-reactive and non-cross reactive antigens from Proteus microbes. Clin Exp Rheumatol 25 (2007) 259-267
37. Wilson C., Rashid T., Tiwana H., Beyan H., Hughes L., Bansal S., et al. Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 30 (2003) 972-978
38. Schellekens G.A., de Jong B.A., van den Hoogen F.H., van de Putte L.B., and van Venrooij W.J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101 (1998) 273-281
39. Nymand G. Maternal smoking and immunity. Lancet ii (1974) 1379-1380
40. Zintzaras E., Dahabreh I.J., Giannouli S., Voulgarelis M., and Moutsopoulos H.M. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Clin Ther 30 (2008) 1939-1955
41. Vital E.M., and Emery P. The development of targeted therapies in rheumatoid arthritis. J Autoimmun 31 (2008) 219-227
42. Wolfe F., and Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 56 (2007) 2886-2895
43. Avorn J., Monane M., Gurwitz J.H., Glynn R.J., Choodnovskiy I., and Lipsitz L.A. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 271 (1994) 751-754
44. Khalafpour S., Ebringer A., Abuljadayel I., and Corbett M. Antibodies to Klebsiella and Proteus microorganisms in ankylosing spondylitis and rheumatoid arthritis patients measured by ELISA. Br J Rheumatol 27 Suppl. 2 (1988) 86-89
45. Deighton C.M., Gray J., Biant A.J., and Walker D.J. Specificity of the Proteus antibody response in rheumatoid arthritis. Ann Rheum Dis 51 (1992) 1206-1207
46. Tiwana H., Wilson C., Cunningham P., Binder A., and Ebringer A. Antibodies to four gram-negative bacteria in rheumatoid arthritis which share sequences with the rheumatoid arthritis susceptibility motif. Br J Rheumatol 35 (1996) 592-594